A research programme by the Access to Medicine Foundation
The foundation

Access to Medicine Foundation

The Foundation stimulates and guides pharmaceutical companies to do more to improve access to medicine. It is an independent non-profit organisation.
Our programmes

Access to Medicine Index

Ranks 20 of the world’s largest pharmaceutical companies based on their efforts to address access to medicine, including in strategy, governance, R&D and pricing. By publicly recognising the best performers, the Index spurs companies to compete to be the best.

Antimicrobial Resistance Benchmark

Tracks what the 17 most active companies in antimicrobial R&D and manufacturing are doing to bring antimicrobial resistance under control. By assessing the level of action, it provides a reality check on progress against AMR.

Access to Vaccines Index

Reports what vaccine companies are doing to ensure all children can be immunised wherever they live. By uncovering what is working and where, this Index helps ensure vaccine markets also reach the poorest and most remote communities.
Type search term(s) and press enter
Often searched for
Index Ranking Vacancies 10-year analysis R&D pipelines AMR antibiotics Investors
  • In the media
  • Hospitals are running out of oxygen to treat...
Media - published on 09 Mar 2021
Share

Hospitals are running out of oxygen to treat covid-19 patients

The Economist's 'Daily chart' covers the dwindling supply of medical oxygen available in low- and middle-income countries. 

Explore further

Media

Asset managers call for ‘fair and equitable’ global efforts to end pandemic

Natalie Kenway for ESG Clarity writes about nearly 150 global investors' call to action for equitable access to COVID-19 treatments and vaccines. 
Media

Global collaboration is the world’s best shot at ending the pandemic – here’s what Big Pharma can do

In a viewpoint for the Telegraph, Dag-Inge Ulstein, Minister of International Development for the Norwegian Government, and John-Arne Røttingen, Chief Executive for the Research Council of Norway (RCN) point to four ways pharma can improve access to medicine.
Media

WHO sounds alarm over COVID-linked oxygen crisis

Lianna Matt McLemon for CIDRAP writes about the shortage of medical oxygen in low- and middle-income countries (LMICs) that has been exacerbated by COVD-19.

Get in touch

Back to top |